Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
Status:
Not yet recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The study aims to explore the ability of Oral activated charcoal to adsorb uremic toxins
limiting the progression of chronic kidney disease and delaying the need for hemodialysis in
patients with CKD stages III and IV.
To compare its effect with the effect of dry seeds as absorbents of uremic toxins